EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective

Hee Jae Choi iD, Shilpa Madari iD, Fenglei Huang iD

Clinical Pharmacokinetics · 2024-06 · 63 (6) · 735-749

DOI: 10.1007/s40262-024-01385-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 13.06.2024. Verfasst von Hee Jae Choi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA. Hauptthemen laut MEDLINE: Drug Interactions, Drug Development, Biomarkers, Membrane Transport Proteins. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug InteractionsDrug DevelopmentBiomarkersMembrane Transport ProteinsHumansDrug IndustryKidneyPharmaceutical PreparationsAnimals

Substanzen

BiomarkersMembrane Transport ProteinsPharmaceutical Preparations

Autor:innen und Institutionen

  • Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA.
  • Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06877, USA. fenglei.huang@boehringer-ingelheim.com.

ORCID-Profile: Hee Jae Choi, Shilpa Madari, Fenglei Huang

Förderung

  • Boehringer Ingelheim

Zitieren

APA

Choi, H. J., Madari, S., & Huang, F. (2024). Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective. Clinical Pharmacokinetics, 63(6), 735-749. https://doi.org/10.1007/s40262-024-01385-0

Vancouver

Choi HJ, Madari S, Huang F. Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective. Clinical Pharmacokinetics. 2024;63(6):735-749. doi:10.1007/s40262-024-01385-0

BibTeX
@article{Choi2024,
  author = {Choi, Hee Jae and Madari, Shilpa and Huang, Fenglei},
  title = {Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective},
  journal = {Clinical Pharmacokinetics},
  year = {2024},
  volume = {63},
  number = {6},
  pages = {735--749},
  doi = {10.1007/s40262-024-01385-0}
}
Kostenlos starten →